Squarepoint
BCYC

Squarepoint’s Bicycle Therapeutics BCYC Stock Holding History

Squarepoint’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,259
Closed -$103K – 4269
2025
Q3 		$103K Buy
13,259
+1,385
+12% +$10.5K ﹤0.01% 4104
2025
Q2 		$82.5K Buy
+11,874
New +$94.6K ﹤0.01% 4218
2022
Q2 		– Sell
-11,700
Closed -$513K – 2881
2022
Q1 		$513K Buy
11,700
+3,500
+43% +$163K ﹤0.01% 1995
2021
Q4 		$499K Buy
+8,200
New +$452K ﹤0.01% 2142
2020
Q3 		– Sell
-10,370
Closed -$163K – 2490
2020
Q2 		$163K Sell
10,370
-2,738
-21% -$42.1K ﹤0.01% 1887
2020
Q1 		$179K Buy
+13,108
New +$167K ﹤0.01% 1514

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
GP
GSK plc London $599M AUM
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Squarepoint's BCYC Position: Q4 2025 in Review

Squarepoint sold out of Bicycle Therapeutics (BCYC) in Q4 2025, closing a stake of 13,259 shares — an estimated $103K sold.

Squarepoint first reported a position in BCYC in Q1 2020 and held it in 6 quarters. The position peaked at $513K in Q1 2022. 109 funds tracked by Wall St. Rank hold BCYC as of Q4 2025.

  • Squarepoint reported no remaining Bicycle Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 13,259 Bicycle Therapeutics shares in Q4 2025, an estimated $103K.
  • Squarepoint first reported a position in Bicycle Therapeutics in Q1 2020 and held it in 6 quarters.
  • Squarepoint's Bicycle Therapeutics position peaked at $513K in Q1 2022.
  • 109 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.